APOGEE THERAPEUTICS INC (APGE) Earnings History & Surprises
NASDAQ:APGE • US03770N1019
73.05 USD
+2.13 (+3%)
At close: Mar 6, 2026
73.05 USD
0 (0%)
After Hours: 3/6/2026, 4:30:02 PM
Past quarterly earnings results for APOGEE THERAPEUTICS INC (APGE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 11, 2026
PeriodQ1 / 2026
EPS Estimate-$1.12
Revenue Estimate
Last Reported
Release DateMar 2, 2026
PeriodQ4 / 2025
EPS Reported-$1.03
EPS Surprise 4.31%
Revenue Surprise %
Beat Rate
25%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -1.03 | -1.08 | 4.31% | 13.45% | - | - | ||
| Q3 2025 | -1.11 | -1.21 | 8.47% | -29.07% | - | - | ||
| Q2 2025 | -1.13 | -1.10 | -2.92% | -89.28% | - | - | ||
| Q1 2025 | -0.95 | -1.27 | 25.36% | -48.44% | - | - | ||
| Q4 2024 | -1.19 | -1.10 | -8.41% | -271.87% | - | - | ||
| Q3 2024 | -0.86 | -0.79 | -9.03% | -68.63% | - | - | ||
| Q2 2024 | -0.60 | -0.62 | 2.99% | 84.21% | - | - | ||
| Q1 2024 | -0.64 | -0.62 | -2.86% | - | - | - | ||
| Q4 2023 | -0.32 | -0.50 | 35.92% | - | - | - | ||
| Q3 2023 | -0.51 | -0.42 | -22.03% | - | - | - | ||
| Q2 2023 | -3.78 | -1.74 | -117.74% | - | - | - | ||
| Q1 2023 | - | - | - | - | ||||
| Q4 2022 | - | - | - | - | ||||
| Q1 2022 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
5.62%
Max EPS beat (4)
25.36%
Min EPS beat (4)
-8.41%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, APGE has beaten EPS estimates in 2 out of 4 releases
In the last 4 quarters, APGE has beaten the EPS estimates by 5.6% on average.
APOGEE THERAPEUTICS INC / APGE Earnings FAQ
When did APOGEE THERAPEUTICS INC (APGE) report earnings last quarter?
APOGEE THERAPEUTICS INC (APGE) last reported earnings on 3/2/2026.
Can you provide information on whether APOGEE THERAPEUTICS INC beat earnings estimates in the last quarter?
APOGEE THERAPEUTICS INC (APGE) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often APOGEE THERAPEUTICS INC beats earnings estimates?
In the last 4 quarters, APOGEE THERAPEUTICS INC (APGE) has beaten EPS estimates in 2 out of 4 releases.